| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |